Award
National Cancer Institute 7R01CA194409-10
sEcad as a novel target and therapy for IGF-1R expressing tumors
Recipient
Not specified
Award Amount
$201,369.00
Ceiling
$201,369.00
Awarded
March 02, 2026
Identifier
7R01CA194409-10
Research grant awarded by NIH/NCI to study soluble E-cadherin as a target and therapy for IGF-1R expressing tumors, focusing on breast cancer.
Description
This is a research grant awarded by the NIH/NCI for a project studying soluble E-cadherin as a target and therapy for IGF-1R expressing tumors, with a focus on breast cancer. The project involves biochemical characterization, in vitro and in vivo studies, and development of targeted therapies.